Column

Did U.S. steal $300 billion from investors in ‘coercive’ takeover of Fannie Mae, Freddie Mac?

The allegations are so sensitive that thousands of supporting documents and even part of the lawsuit have been blacked out at the government’s request.

Richard Vague makes a big fintech bet on WealthHub; William Penn buys Fidelity, Washington

Investors add $1.4 million for WealthHub; William Penn bank in Bucks County buys two smaller mutuals.

Richard Vague makes a big fintech bet on WealthHub; William Penn buys Fidelity, Washington

Investors add $1.4 million for WealthHub; William Penn bank in Bucks County buys two smaller mutuals.

Arnold Staloff, 74, Philadelphia currency trader and innovator

Arnold Staloff, partner in the former Bloom Staloff Corp., survived strokes but knew his personality had changed, say his daughters. Even then, he always listened.

Arnold Staloff, 74, Philadelphia currency trader and innovator

Arnold Staloff, partner in the former Bloom Staloff Corp., survived strokes but knew his personality had changed, say his daughters. Even then, he always listened.

Column

Will David L. Cohen do for the people of Philadelphia what he did for Comcast?

Cohen’s decision to start disengaging at Comcast has some Philadelphians hopeful he will redirect more energy to public purposes.
Column

Will David L. Cohen do for the people of Philadelphia what he did for Comcast?

Cohen’s decision to start disengaging at Comcast has some Philadelphians hopeful he will redirect more energy to public purposes.
More Stories
Column

PhillyBioCapital: $75M for Limelight ‘leapfrog’ gene therapy; LLR’s $40M to Suvoda

“Limelight Bio has the potential to leapfrog the prevailing gene therapy and editing approaches to tackle a much broader array of genetic disorders,” one investor said.

Column

No to ‘Chinese penny stock’ deal with firm tied to Trump and Biden backers

New Castle County's top official rejected a plan to swap shares of Ideanomics Inc. for unused software, as collateral for a $3 million loan to a Wilmington stock exchange that has not created promised jobs.

PhillyBioCapital: $80M for Impulse heart pumps; LLR gives Relay $30M to text more

South Jersey-based Impulse Dynamics plans to take its FDA-approved, improved heartbeat assistance system to market

Column

New Trump tariffs feed fears for Pa. steel, port jobs

“The government is really hurting the little guy," says a steel company president. In Philadelphia's port, "the tonnage is down."

Martha Stewart’s private-equity bosses offer $50M for Destination Maternity — without stores

Marquee Brands, which owns Martha Stewart and other brands, is the default bidder for money-losing, South Jersey-based Destination Maternity stores.

Column

DuPont vs. Chemours: Yes, it’s ‘about money,’ pollution, Hollywood, and partisan Washington

Plaintiff lawyers are Democrats, chemical makers are Republicans, and Hollywood has piled on against the shrunken DuPont Co.

Pa. investor Graham Partners raises $645 million to buy private firms

Graham Partners, founded by a former Goldman Sachs investment banker, has raised $645 million from investors for its latest fund, Graham Partners V, L.P., according to regulatory regulatory filings.

Packaging plant just outside Philly to shut, 80 jobs lost

Union Packaging, for 20 years a rare Philadelphia-area manufacturing success story, is shutting down, owner Michael Pearson said.

Warren ‘Pete’ Musser, longtime Pennsylvania investor, dead at 92

Musser ran Safeguard Scientifics and helped the dealmakers who founded Comcast and QVC.

AdaptHealth follows $30M McKesson buy with Advanced purchase; Roche-Spark deal nears deadline

AdaptHealth buys McKesson unit for $30M; Spark-Roche deal held til December

Column

Doctor with Penn, Temple roots is Trump’s choice for FDA top job

Stephen Hahn headed the radiation oncology department at Penn's medical school for nearly a decade. He was also grilled by congress members a decade ago for improper and ineffective care given to veterans at the Philadelphia VA.

Biotech IPO frenzy brings some Philly firms into the stock market before they sell products or earn profits

That's risky, but going public gives fledgling companies a way to boost clients, sales and profits.

Cleared to reopen, a year after toxic leak stopped Thanksgiving traffic

State approves Croda ethylene oxide unit to reopen, a year after accident stopped Thanksgiving traffic.

SPECIAL REPORTS
Investigative reports, featured series, and guides to living in the Philadelphia region, brought to you by The Inquirer.
WHAT ARE YOU CURIOUS ABOUT?
Send us your burning questions, or vote on other readers' questions that pique your interest. Our journalists will work to answer them.